Nutex Health, Inc. (NUTX) - Stock Analysis

Last updated: Sep 6, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.

Loading chart data...

Idea window: 12/31/2025 – 1/7/2026Sector: Healthcare

AI Analyst Overview

Last Price
$200.24
Market Cap
$1.38B
1D Return
+2.58%
YTD Return
+21.64%

Loading chart data...

Valuation Metrics

P/E
7.6
P/B
3.5
P/S
1.6
EV/EBITDA
3.7
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Strong Margins • Improved Liquidity • Cash Flow NUTX shows strong profitability, improving liquidity and low valuation multiples, but weaker quarterly cash flow, high receivables, leverage, and earnings-quality concerns warrant caution.

Profitability
CashFlowRisk

Price Behavior

6.0

Key Price Behavior Insights: • Constructive momentum • Resistance rejection • Elevated volatility Support Level: $185–$188 Resistance Level: $195–$198 NUTX remains constructive but volatile over the last month, holding above $187 support while a decisive break above $195–$198 resistance would strengthen the bullish setup.

Bullish
Volatile

Sentiment & News

7.0

Key News Insights: • EBITDA Improvement • Hospital Expansion • Cybersecurity Risk Nutex Health's profitability, expansion, and bullish analyst outlook offset revenue decline, though a reported cyberattack investigation adds material risk.

Growth
CyberRisk
AI

AI Summary

6.0
Neutral

NUTX is now a sustainability trade—not an expansion story—where investors should require proof that exceptional margins and cash flow can persist despite 13% revenue decline, large receivables, and cyber/legal costs; avoid chasing near highs until recurring profitability and collections validate the low valuation.

MarginUpside
CyberLegalRisk
CashFlowValidation
AI summary updated 5 days ago

Description

Nutex Health, Inc. is a Houston-based, technology-enabled healthcare services company with two operating segments: a Hospital division that owns and operates 21 facilities across eight states, including micro-hospitals, specialty hospitals and hospital outpatient departments; and a Population Health Management division that manages provider networks and delivers management and administrative support to affiliated hospitals and physician groups. The population health unit also maintains a proprietary cloud platform that consolidates clinical and administrative data from multiple systems to provide a comprehensive view of patients and providers and to support care delivery.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Dec 31Jan 7NUTXNutex Health, Inc.
Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.
Closed+8.2%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.